Back to FDA Applications sponsored by INCYTE CORP

FDA Drug Application 202192 by INCYTE CORP

Application Number202192
Application Type New Drug Application
Sponsor ApplicantINCYTE CORP
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP011/16/2011N30596000 11/16/2011
AP011/16/2011N30598000 11/16/2011
AP011/16/2011N31371000 1/9/2012
AP011/16/2011N31372000 1/9/2012
AP06/21/2012SLR32984001 6/22/2012
AP06/21/2012SLR32986001 6/25/2012
AP06/12/2013SE836286003 6/13/2013
AP06/12/2013SE836315003 6/18/2013
AP011/25/2013SLR37934005 11/26/2013
AP011/25/2013SLR37944005 11/27/2013
AP07/25/2014SE840013006 7/28/2014
AP07/25/2014SE840016006 7/28/2014
AP012/4/2014SE841155008 12/4/2014
AP012/4/2014SE841169008 12/5/2014
AP012/15/2014SLR41263009 12/16/2014
AP012/15/2014SLR41266009 12/16/2014
AP03/10/2016SE845424012 3/14/2016
AP03/10/2016SE845444012 3/15/2016

Back to FDA Applications sponsored by INCYTE CORP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.